NI
Nextech Invest Portfolio holdings
AUM
$528M
This Quarter Return
-15.31%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$616M
AUM Growth
+$616M
(-13%)
Cap. Flow
+$55.2M
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
93.61%
Holding
15
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$57.1M |
Top Sells
| 1 |
ARS Pharmaceuticals
SPRY
|
$1.86M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Revolution Medicines
RVMD
$7.1B
| $332M | 53.94% | 7,601,087 +1,304,347 | +21% | +$57.1M |
|
2
Tyra Biosciences
TYRA
$675M
| $56.4M | 9.15% | 4,055,861 | – | – |
|
3
Oric Pharmaceuticals
ORIC
$994M
| $42.7M | 6.92% | 5,285,714 | – | – |
|
|
CRGX
4
DELISTED
CARGO Therapeutics
CRGX
| $38.1M | 6.18% | 2,642,502 | – | – |
|
5
Arvinas
ARVN
$568M
| $27M | 4.38% | 1,408,394 | – | – |
|
6
Mersana Therapeutics
MRSN
$36.5M
| $17.3M | 2.8% | 12,067,246 | – | – |
|
7
Tango Therapeutics
TNGX
$747M
| $17.1M | 2.77% | 5,533,980 | – | – |
|
8
Zymeworks
ZYME
$1.12B
| $16.3M | 2.65% | 1,113,946 | – | – |
|
9
Relay Therapeutics
RLAY
$619M
| $15.8M | 2.57% | 3,846,409 | – | – |
|
10
Cullinan Oncology
CGEM
$445M
| $13.9M | 2.25% | 1,141,145 | – | – |
|
|
ALMS
11
Alumis Inc. Common Stock
ALMS
$479M
| $11.6M | 1.88% | 1,476,998 | – | – |
|
|
12
ARS Pharmaceuticals
SPRY
$1.15B
| $9.88M | 1.6% | 936,729 -176,300 | -16% | -$1.86M |
|
13
Context Therapeutics
CNTX
$75.4M
| $7.79M | 1.26% | 7,419,355 | – | – |
|
|
SLN
14
Silence Therapeutics
SLN
$227M
| $6.55M | 1.06% | 952,400 | – | – |
|
|
BOLD
15
Boundless Bio
BOLD
$25.1M
| $3.56M | 0.58% | 1,228,069 | – | – |
|